A Pilot Study to Evaluate the Safety and Feasibility of Induction of Mixed Chimerism in Severe Aplastic Anemia Patients With COH-MC-17: A Non-Myeloablative/ Reduced-Intensity, Conditioning Regimen and CD4+ T-Cell-Depleted Haploidentical Hematopoietic Transplant
Latest Information Update: 06 Jan 2025
At a glance
- Drugs Pentostatin (Primary) ; Cyclophosphamide
- Indications Aplastic anaemia
- Focus Adverse reactions
Most Recent Events
- 06 Nov 2024 Planned initiation date changed from 1 Oct 2024 to 15 Dec 2024.
- 28 Aug 2024 Planned End Date changed from 26 Oct 2026 to 18 Jun 2027.
- 28 Aug 2024 Planned primary completion date changed from 26 Oct 2026 to 18 Jun 2027.